ANAB (AnaptysBio, Inc.) — Stock Analysis, Catalysts & AI Research

AnaptysBio, Inc.

$58.22

Health CareBiotechnology

The Read: 2% after Q1 2026 earnings met expectations without upside surprise.

ANAB

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

AnaptysBio, Inc.

$58.22

Health CareBiotechnology

The Read: 2% after Q1 2026 earnings met expectations without upside surprise.

ANAB

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Start your free trial to unlock active Expected Moves for ANAB

Expected Moves

AnaptysBio, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Start your free trial to unlock active Expected Moves for ANAB

Expected Moves

AnaptysBio, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow